We’d love your feedback!

We’re working on new tools and we want to make sure they’re truly useful to you.

Can you spare 30 seconds to answer 3 quick questions?

Your feedback directly shapes the future of Finviz.

Take the Survey

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 13 02:26PM ET
3.94
Dollar change
+0.23
Percentage change
6.33
%
Index- P/E- EPS (ttm)-0.21 Insider Own5.71% Shs Outstand26.35M Perf Week13.04%
Market Cap108.27M Forward P/E- EPS next Y-0.12 Insider Trans0.00% Shs Float25.88M Perf Month121.63%
Income-5.62M PEG- EPS next Q-0.06 Inst Own19.60% Short Float1.19% Perf Quarter13.69%
Sales19.61M P/S5.52 EPS this Y-10.00% Inst Trans-8.99% Short Ratio0.37 Perf Half Y108.73%
Book/sh1.09 P/B3.62 EPS next Y45.45% ROA-14.23% Short Interest0.31M Perf Year170.21%
Cash/sh0.63 P/C6.29 EPS next 5Y70.76% ROE-18.09% 52W Range1.18 - 3.92 Perf YTD115.57%
Dividend Est.- P/FCF- EPS past 5Y21.98% ROI-19.49% 52W High0.64% Beta1.38
Dividend TTM- Quick Ratio3.40 Sales past 5Y-6.49% Gross Margin83.59% 52W Low234.32% ATR (14)0.20
Dividend Ex-Date- Current Ratio3.50 EPS Y/Y TTM3.49% Oper. Margin-31.97% RSI (14)79.06 Volatility4.65% 5.33%
Employees66 Debt/Eq0.01 Sales Y/Y TTM-4.15% Profit Margin-28.64% Recom3.00 Target Price5.33
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-162.67% Payout- Rel Volume1.60 Prev Close3.71
Sales Surprise11.83% EPS Surprise42.64% Sales Q/Q14.07% EarningsMar 19 AMC Avg Volume825.93K Price3.94
SMA2018.25% SMA5052.46% SMA20088.24% Trades Volume1,021,418 Change6.33%
Date Action Analyst Rating Change Price Target Change
Apr-17-25Downgrade Laidlaw Buy → Hold
Apr-17-25Downgrade BTIG Research Buy → Neutral
Jan-18-22Downgrade Guggenheim Buy → Neutral
Apr-22-21Initiated Guggenheim Buy $24
Mar-23-21Initiated BTIG Research Buy $25
Feb-26-21Initiated Oppenheimer Outperform $27
Jan-29-21Initiated Cantor Fitzgerald Overweight $19
Dec-03-20Initiated B. Riley Securities Buy $15
Feb-05-20Initiated JMP Securities Mkt Outperform $15
Jan-09-20Initiated Lake Street Buy $14
Today 11:28AM
Apr-30-25 10:53AM
Apr-29-25 11:12AM
08:00AM
Apr-15-25 04:01PM
10:19AM Loading…
Apr-08-25 10:19AM
Mar-20-25 03:02AM
Mar-19-25 07:01PM
07:00PM
04:17PM
04:01PM
Mar-11-25 08:00AM
Mar-05-25 02:04PM
Feb-27-25 05:55PM
Feb-26-25 02:46PM
07:59AM Loading…
Feb-21-25 07:59AM
Feb-20-25 11:44AM
Feb-19-25 08:00AM
Feb-03-25 07:12PM
Jan-27-25 09:31AM
08:00AM
Dec-11-24 10:00AM
Dec-04-24 05:00PM
Nov-26-24 01:00PM
Nov-14-24 11:22AM
Nov-13-24 04:12PM
04:01PM
Nov-12-24 08:00AM
Nov-06-24 08:00AM
Nov-05-24 08:00AM
02:00PM Loading…
Oct-24-24 02:00PM
Oct-16-24 08:00AM
Oct-09-24 06:19PM
Oct-03-24 08:00AM
Sep-20-24 08:00AM
Sep-11-24 08:00AM
Aug-13-24 04:14PM
04:01PM
Aug-06-24 08:00AM
Jul-29-24 08:00AM
Jun-26-24 08:00AM
Jun-04-24 08:00AM
May-17-24 07:00AM
May-16-24 03:01AM
May-15-24 11:52AM
08:00AM
07:57AM
May-08-24 09:49AM
May-02-24 08:00AM
Apr-11-24 08:00AM
Apr-09-24 08:00AM
Apr-08-24 04:29PM
Apr-03-24 08:00AM
Apr-02-24 08:00AM
Mar-19-24 09:00AM
Mar-14-24 02:00PM
Mar-13-24 08:46AM
07:01AM
Mar-12-24 04:22PM
04:01PM
Mar-01-24 07:30AM
Feb-28-24 08:05AM
Feb-27-24 09:05AM
08:05AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Dec-18-23 08:00AM
Dec-05-23 06:00AM
Nov-28-23 08:00AM
Nov-27-23 08:00AM
Nov-22-23 08:12AM
Nov-20-23 08:00AM
Nov-14-23 10:56AM
08:00AM
Nov-13-23 04:06PM
04:01PM
Oct-30-23 08:00AM
Oct-24-23 04:03PM
Oct-23-23 08:01AM
Oct-08-23 07:19PM
Sep-01-23 05:07AM
Aug-27-23 11:53AM
Aug-16-23 08:00AM
Aug-15-23 07:58AM
Aug-14-23 05:48PM
04:01PM
08:00AM
Aug-07-23 11:49AM
Jul-31-23 08:00AM
Jul-25-23 09:34PM
Jul-23-23 09:49AM
Jul-18-23 08:00AM
Jul-12-23 08:00AM
Jul-10-23 08:00AM
Jul-07-23 02:30PM
Jun-25-23 02:17PM
Jun-08-23 06:31AM
May-18-23 04:40PM
08:00AM
May-16-23 11:13AM
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.